Gennova starts enrolment for Phase I/II human trials for its mRNA vaccine

NEW DELHI: India’s mRNA-based covid-19 vaccine candidate-HGCO19, developed by Pune-based biotechnology company Gennova Biopharmaceuticals Ltd has received additional government funding for its clinical studies.